Steven Kiel Participates in The Investors Roundtable #21

Written By Elisa Sanchez

Arquitos Capital’s Steven Kiel joined Robert Kraft’s The Investors Roundtable to discuss COVID-19 vaccine trial results and investing in healthcare.

Elisa Sanchez
Previous

Willow Oak Releases Episode 9 of Value Hour
Next

Willow Oak Releases Third-quarter Letter to Shareholders